Literature DB >> 28799242

Negative regulation of Nod-like receptor protein 3 inflammasome activation by T cell Ig mucin-3 protects against peritonitis.

Wei Wang1,2, Qingzhu Shi1, Shuaijie Dou1,3, Ge Li1, Xinhui Shi1, Xingwei Jiang1, Zhiding Wang1, Dandan Yu1, Guojiang Chen1, Renxi Wang1, He Xiao1, Chunmei Hou1, Jiannan Feng1, Beifen Shen1, Yuanfang Ma2, Gencheng Han1.   

Abstract

The Nod-like receptor protein 3 (NLRP3) inflammasome plays roles in host defence against invading pathogens and in the development of autoimmune damage. Strict regulation of these responses is important to avoid detrimental effects. Here, we demonstrate that T cell Ig mucin-3 (Tim-3), an immune checkpoint inhibitor, inhibits NLRP3 inflammasome activation by damping basal and lipopolysaccharide-induced nuclear factor-κB-mediated up-regulation of NLRP3 and interleukin-1β during the priming step and basal and ATP/lipopolysaccharide-induced ATP production, K+ efflux, and reactive oxygen species production during the activation step. Residues Y256/Y263 in the C-terminal region of Tim-3 are required for these inhibitory effects on the NLRP3 inflammasome. In mice with alum-induced peritonitis, blockade of Tim-3 exacerbates peritonitis by overcoming the inhibitory effect of Tim-3 on NLRP3 inflammasome activation, while transgenic expression of Tim-3 attenuates inflammation by inhibiting NLRP3 inflammasome activation. Our results show that Tim-3 is a critical negative regulator of NLRP3 inflammasome and provides a potential target for intervention of diseases with uncontrolled inflammasome activation.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  NLRP3 inflammasome; Tim-3; macrophage

Mesh:

Substances:

Year:  2017        PMID: 28799242      PMCID: PMC5721242          DOI: 10.1111/imm.12812

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  41 in total

Review 1.  NLRP3 inflammasomes link inflammation and metabolic disease.

Authors:  Dominic De Nardo; Eicke Latz
Journal:  Trends Immunol       Date:  2011-07-04       Impact factor: 16.687

2.  K⁺ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter.

Authors:  Raúl Muñoz-Planillo; Peter Kuffa; Giovanny Martínez-Colón; Brenna L Smith; Thekkelnaycke M Rajendiran; Gabriel Núñez
Journal:  Immunity       Date:  2013-06-27       Impact factor: 31.745

3.  Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease.

Authors:  Laurent Monney; Catherine A Sabatos; Jason L Gaglia; Akemi Ryu; Hanspeter Waldner; Tatyana Chernova; Stephen Manning; Edward A Greenfield; Anthony J Coyle; Raymond A Sobel; Gordon J Freeman; Vijay K Kuchroo
Journal:  Nature       Date:  2002-01-31       Impact factor: 49.962

4.  Aryl hydrocarbon receptor negatively regulates NLRP3 inflammasome activity by inhibiting NLRP3 transcription.

Authors:  Wanwan Huai; Rui Zhao; Hui Song; Jing Zhao; Lei Zhang; Lining Zhang; Chengjiang Gao; Lihui Han; Wei Zhao
Journal:  Nat Commun       Date:  2014-08-20       Impact factor: 14.919

Review 5.  Mechanisms of NOD-like receptor-associated inflammasome activation.

Authors:  Haitao Wen; Edward A Miao; Jenny P-Y Ting
Journal:  Immunity       Date:  2013-09-19       Impact factor: 31.745

6.  Taming dendritic cells with TIM-3: another immunosuppressive strategy used by tumors.

Authors:  Jaina Patel; Erica N Bozeman; Periasamy Selvaraj
Journal:  Immunotherapy       Date:  2012-12       Impact factor: 4.196

7.  Galectin-9 signaling through TIM-3 is involved in neutrophil-mediated Gram-negative bacterial killing: an effect abrogated within the cystic fibrosis lung.

Authors:  Isabel Vega-Carrascal; David A Bergin; Oliver J McElvaney; Cormac McCarthy; Nessa Banville; Kerstin Pohl; Mitsuomi Hirashima; Vijay K Kuchroo; Emer P Reeves; Noel G McElvaney
Journal:  J Immunol       Date:  2014-01-29       Impact factor: 5.422

8.  Dysregulated Tim-3 expression and its correlation with imbalanced CD4 helper T cell function in ulcerative colitis.

Authors:  Fengmin Shi; Xiaoqin Guo; Xingwei Jiang; Ping Zhou; Yan Xiao; Tingting Zhou; Guojiang Chen; Zhi Zhao; He Xiao; Chunmei Hou; Xinying Li; Xiaomei Yang; Renxi Wang; Jiannan Feng; Beifen Shen; Yan Li; Gencheng Han
Journal:  Clin Immunol       Date:  2012-09-18       Impact factor: 3.969

9.  LRRFIP2 negatively regulates NLRP3 inflammasome activation in macrophages by promoting Flightless-I-mediated caspase-1 inhibition.

Authors:  Jing Jin; Qian Yu; Chaofeng Han; Xiang Hu; Sheng Xu; Qingqing Wang; Jianli Wang; Nan Li; Xuetao Cao
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

Review 10.  NLRP3 inflammasome and its inhibitors: a review.

Authors:  Bo-Zong Shao; Zhe-Qi Xu; Bin-Ze Han; Ding-Feng Su; Chong Liu
Journal:  Front Pharmacol       Date:  2015-11-05       Impact factor: 5.810

View more
  6 in total

1.  Increased Tim-3 expression alleviates liver injury by regulating macrophage activation in MCD-induced NASH mice.

Authors:  Xianhong Du; Zhuanchang Wu; Yong Xu; Yuan Liu; Wen Liu; Tixiao Wang; Chunyang Li; Cuijuan Zhang; Fan Yi; Lifen Gao; Xiaohong Liang; Chunhong Ma
Journal:  Cell Mol Immunol       Date:  2018-05-07       Impact factor: 11.530

Review 2.  An update on cell intrinsic negative regulators of the NLRP3 inflammasome.

Authors:  Barun Poudel; Prajwal Gurung
Journal:  J Leukoc Biol       Date:  2018-01-26       Impact factor: 4.962

Review 3.  Immune regulation by Tim-3.

Authors:  Hridesh Banerjee; Lawrence P Kane
Journal:  F1000Res       Date:  2018-03-14

Review 4.  Immunomodulatory Properties of Immune Checkpoint Inhibitors-More than Boosting T-Cell Responses?

Authors:  Michael Kuske; Maximilian Haist; Thomas Jung; Stephan Grabbe; Matthias Bros
Journal:  Cancers (Basel)       Date:  2022-03-28       Impact factor: 6.639

5.  Clinical Significance of High-Mobility Group Box 1 Protein (HMGB1) and Nod-Like Receptor Protein 3 (NLRP3) in Patients with Ulcerative Colitis.

Authors:  YanMin Chen; Dong Wu; LingJia Sun
Journal:  Med Sci Monit       Date:  2020-01-05

6.  Role of Gate-16 and Gabarap in Prevention of Caspase-11-Dependent Excess Inflammation and Lethal Endotoxic Shock.

Authors:  Naoya Sakaguchi; Miwa Sasai; Hironori Bando; Youngae Lee; Ariel Pradipta; Ji Su Ma; Masahiro Yamamoto
Journal:  Front Immunol       Date:  2020-09-15       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.